Clinical use of non-A botulinum toxins: botulinum toxin type C and botulinum toxin type F.
Neurotox Res
; 9(2-3): 127-31, 2006 Apr.
Article
em En
| MEDLINE
| ID: mdl-16785109
ABSTRACT
Botulinum neurotoxin (BoNT) serotype A is commonly used in the treatment of focal dystonia, but some patients are primarily or become secondarily resistant to it. Consequently, other serotypes have to be used when immuno-resistance is proven. In the literature, patients with focal dystonia have been treated with BoNT serotype F with clinical benefit but with short lasting effects. Recently, BoNT serotype C has been used with positive clinical outcome. An update on the clinical use of BoNT serotype F and BoNT serotype C is provided.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Torcicolo
/
Blefaroptose
/
Toxinas Botulínicas
Limite:
Adult
/
Aged
/
Animals
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Ano de publicação:
2006
Tipo de documento:
Article